Oriscience Cell Counting Kit-8 (CCK-8試劑盒)
市場價:¥ 130.00
銷售價:¥ 130.00
貨號:CB101-1ml
貨期:現(xiàn)貨
本產(chǎn)品僅供科研使用。請勿用于醫(yī)藥、臨床診斷或治療,食品及化妝品等用途。
成功加入購物車
Oriscience Cell Counting Kit-8 (CCK-8) 是一種基于WST-8的廣泛應(yīng)用于細(xì)胞增殖和細(xì)胞毒性檢測的快速、高靈敏度試劑盒。其原理為高度水溶性的四唑鹽WST-8在電子載體存在下,被細(xì)胞產(chǎn)生的脫氫酶還原產(chǎn)生水溶性甲臜染料,產(chǎn)生的甲臜量與活細(xì)胞的數(shù)量成正比。通過測量450 nm處的吸光度可間接反映活細(xì)胞的數(shù)量。

操作簡單---即開即用,只需要一步可檢測結(jié)果
安全低毒---細(xì)胞毒性非常低,不影響后續(xù)實驗
結(jié)果可靠---靈敏度比MTT法更高,重現(xiàn)性好、穩(wěn)定性高
應(yīng)用性廣---細(xì)胞增殖測定、細(xì)胞毒性、藥物篩選等
4℃避光保存

A549細(xì)胞按500, 1000, 2000, 4000, 8000, 16000, 32000, 40000 cells接種至96孔板中,按10 μl/well加入Oriscience CCK-8與某日本公司CCK-8試劑孵育1 h后,測量450 nm處吸光度,計算R2值。結(jié)果顯示,Oriscience CCK-8具有更好的檢測靈敏度和更寬的線性范圍。
1. 若細(xì)胞培養(yǎng)時間較長,建議不使用96孔板外周一圈,并在其中加入PBS以緩解蒸發(fā),有助于提高實驗的均一性。
2. 本試劑盒的檢測依賴于脫氫酶催化的反應(yīng),所以還原劑、抗氧化劑等物質(zhì)會干擾檢測,如果待測體系中存在較多此類物質(zhì),須設(shè)法去除。
3. 檢測450 nm吸光度前需確保每個孔內(nèi)沒有氣泡,否則會干擾測定。
4. 本產(chǎn)品僅供科研使用。請勿用于醫(yī)藥、臨床診斷或治療,食品及化妝品等用途。
pdf
下載
1. 張祺琪, 王俊梅, 岳子奇, 等. LPS 對牦牛瘤胃上皮細(xì)胞補體 C3 激活和 ATP 生成代謝的影響[J]. 畜牧獸醫(yī)學(xué)報, 2023, 54(11): 4664-4675
2. Tang Y, Liu Y, Wang X, et al. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway[J]. BMC cancer, 2024, 24(1): 204
3. Du, A., Ma, X., Huang, T., Pan, H., Li, Q., Zhou, Y., ... & Wang, Z. (2025). Time-series transcriptome profiling of liver regeneration in ALLPS models of mice identifies the Cyp8b1 as a potential target for hepatocyte proliferation. Biochemical and Biophysical Research Communications, 152690.
4. Li, Y., Hao, G., Fan, J., Wu, F., Yao, X., Liang, Y., ... & Gu, X. (2025). A novel calreticulin of Psoroptes ovis regulated keratinocyte function resulting in host skin barrier dysfunction: implications for involvement in the pathogenesis of psoroptic mange. Parasites & Vectors, 18(1), 198.
5. Huang, Y., Xu, L., Yang, L., Wu, Z., Li, L., Dai, Y., ... & Xu, M. (2025). Targeting circGDI2 disrupt HNRNPC-mediated mPORCN stabilization and enhance LGK-974 anti-tumor therapy in hepatocellular carcinoma.
6. Liao, X., Si, H., Lai, Y., Zhang, X., Feng, Y., Zhou, T., ... & Yu, L. (2025). Porphyromonas gingivalis-OMVs promote the epithelial-mesenchymal transition of oral squamous cell carcinoma by inhibiting ferroptosis through the NF-κB pathway. Journal of Oral Microbiology, 17(1), 2482924.
7. Shang, X., Zheng, X., Jiang, A., Zhao, N., Chen, Y., Liu, N., ... & Yao, Y. (2025). Identification of MDM4 as a Prognostic Biomarker and a Target for Therapeutics in Colorectal Cancer. Biotechnology and Applied Biochemistry.
8. Lu, F., Li, E., Gao, Y., Zhang, Y., Kong, L., & Yang, X. (2025). Dapagliflozin modulates hepatic lipid metabolism through the proprotein convertase subtilisin/kexin type 9/low density lipoprotein receptor pathway. Diabetes, Obesity and Metabolism, 27(4), 2096-2109.
9. Liu, R., Zhou, J., Zhou, J., Liu, F., Liu, Y., Meng, J., ... & Du, J. (2025). MiR‐221‐3p Attenuates IL‐33‐Induced Mast Cell Cytokine Expression by Targeting KIT. In International Forum of Allergy & Rhinology (p. e23558).
Shen, L., Chen, L., Yang, J., Liu, C., Liao, H., Yu, Q., ... & Yang, Y. (2025). Chrysin inhibits hypertrophic scar formation through TGF-β/Smad signaling pathways. Journal of Molecular Histology, 56(5), 298.
10. Luo, F., Li, D., Yang, Y., Liu, J., Mao, R., Huang, Y., ... & Zhang, X. (2025). Quantitative features of osteo-bioactive Ti surfaces at the atomic/molecular level. Journal of Materials Chemistry B, 13(3), 1064-1078.